LSV Asset Management Trims Stake in Sabra Healthcare REIT, Inc. $SBRA

LSV Asset Management lowered its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 4.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,618,915 shares of the real estate investment trust’s stock after selling 153,400 shares during the quarter. LSV Asset Management owned about 1.51% of Sabra Healthcare REIT worth $67,457,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in SBRA. Focus Partners Wealth increased its stake in Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after acquiring an additional 2,375 shares during the last quarter. KLP Kapitalforvaltning AS grew its holdings in shares of Sabra Healthcare REIT by 7.4% during the second quarter. KLP Kapitalforvaltning AS now owns 49,500 shares of the real estate investment trust’s stock worth $913,000 after purchasing an additional 3,400 shares in the last quarter. Vanguard Personalized Indexing Management LLC grew its holdings in shares of Sabra Healthcare REIT by 23.5% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 26,204 shares of the real estate investment trust’s stock worth $483,000 after purchasing an additional 4,991 shares in the last quarter. CWM LLC increased its position in shares of Sabra Healthcare REIT by 22.8% in the second quarter. CWM LLC now owns 15,945 shares of the real estate investment trust’s stock worth $294,000 after purchasing an additional 2,960 shares during the last quarter. Finally, Sequoia Financial Advisors LLC bought a new position in shares of Sabra Healthcare REIT in the second quarter worth approximately $449,000. Institutional investors own 99.40% of the company’s stock.

Analysts Set New Price Targets

SBRA has been the subject of several research analyst reports. Wall Street Zen lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. Wells Fargo & Company raised their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. UBS Group assumed coverage on shares of Sabra Healthcare REIT in a report on Tuesday, November 18th. They set a “neutral” rating and a $20.00 price objective for the company. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. Finally, Truist Financial raised their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a research report on Tuesday, January 20th. Four equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $21.11.

Key Headlines Impacting Sabra Healthcare REIT

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Management issued strong FY‑2026 EPS guidance of $1.55–$1.59, well above the cited consensus of $1.06, which is the primary bullish catalyst for the stock as it implies meaningful earnings acceleration. Sabra Reports Fourth Quarter 2025 Results; Introduces 2026 Guidance
• Positive Sentiment: Reported Q4 EPS of $0.38 beat the $0.37 consensus by $0.01; revenue was essentially flat with estimates and grew ~16% year‑over‑year, showing underlying top‑line momentum. Q4 Press Release / Slides
• Positive Sentiment: FFO/AFFO metrics for Q4 (FFO $0.36; normalized AFFO ~$0.38) and improved revenue mix (noted strength in SHOP segments) support the higher guidance and the dividend outlook. Sabra: Q4 Earnings Snapshot
• Neutral Sentiment: The company issued a 2026 outlook and dividend update alongside results; dividend confirmation is supportive but already priced in for yield‑sensitive REIT investors. Sabra Healthcare REIT Issues 2026 Outlook and Dividend
• Negative Sentiment: A BMO analyst kept a cautious/hold stance, pointing to a softer FFO outlook in some segments and uncertainty around an RCA loan exposure (credit/collection risk), which increases downside risk if those issues persist. Analyst Note: Hold Rating Cites FFO/Loan Uncertainty
• Negative Sentiment: Though EPS beat was marginal, revenue narrowly missed estimates — a reminder that operational execution and FFO conversion matter for REIT valuation, and any future misses could weigh on the shares. Q4 Press Release / Slides

Sabra Healthcare REIT Trading Up 3.3%

SBRA stock opened at $20.25 on Friday. The company has a market capitalization of $5.05 billion, a PE ratio of 28.13, a price-to-earnings-growth ratio of 1.36 and a beta of 0.67. The company has a debt-to-equity ratio of 0.92, a quick ratio of 5.19 and a current ratio of 5.19. Sabra Healthcare REIT, Inc. has a one year low of $15.60 and a one year high of $20.27. The company’s 50 day moving average price is $19.02 and its two-hundred day moving average price is $18.75.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Thursday, February 12th. The real estate investment trust reported $0.38 EPS for the quarter, beating the consensus estimate of $0.37 by $0.01. The company had revenue of $201.35 million for the quarter, compared to analyst estimates of $201.97 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The firm’s quarterly revenue was up 16.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date of this dividend is Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 166.67%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.